The impact of LEAVO study in Greece
Sign Up to like & getrecommendations! Published in 2019 at "Eye"
DOI: 10.1038/s41433-019-0714-6
Abstract: Macular edema is the leading cause of visual impairment in patients with central retinal vein occlusion (CRVO) [1]. Currently, intravitreal anti-vascular growth factor (antiVEGF) agents have been considered as the gold standard in the treatment… read more here.
Keywords: ranibizumab; bevacizumab; treatment; leavo study ... See more keywords